How HealthWright Technologies Enables Physicians to Streamline Non-Invasive Cardiovascular Diagnostics

1 | Why “Fast, Non-Invasive & Billable” Is the New Standard

Manual Doppler ABI is still guideline-recommended, yet real-world limitations—slow workflows, operator variability, and false-negatives in calcified vessels—often push patients past the early-intervention window. Modern outpatient settings need diagnostics that are:

• Rapid: < 10 minutes of chair time
  
• Comprehensive: vascular and autonomic insight in one pass
  
• Audit-proof: CPT definitions that withstand payer scrutiny
  

HealthWright Technologies Inc satisfies all three with the CMAT Advantage, a single CMAT device that combines ABI, pulse-volume recording (PVR), autonomic nervous-system (ANS) metrics, and sudomotor analysis in one visit.

2 | What Makes CMAT Advantage Different?

Take-away: CMAT Advantage widens diagnostic scope and adds two additional CPT opportunities per patient.

3 | Workflow: Check-In to Signed Chart in Six Steps

Net added chair time: ~3 minutes beyond standard vitals.

4 | CPT Coding Summary

Each code may be billable when the corresponding test is medically necessary and documented for a symptomatic or at-risk patient; coverage and amounts vary by payer.

5 | Implementation Toolkit from HealthWright Technologies

HealthWright Technologies provides these resources to supported practices—no extra SaaS fees.

6 | Clinical Value in Practice

Because the CMAT Advantage System captures vascular and autonomic measurements in a single non-invasive session, it can surface findings—such as peripheral arterial disease in patients with calcified vessels or early autonomic changes—that an ABI-only test may miss. The objective data supports the physician’s assessment and helps document medical necessity; it does not, on its own, diagnose or treat disease.

7 | Decision Checklist for Busy Physicians

☐ Clinical evidence & FDA clearance reviewed
☐ Reimbursement support in place (sample claims, coding hotline)
☐ On-site or virtual training scheduled
☐ Consumable pricing & auto-ship terms secured
☐ Section 179 tax impact modeled

HealthWright’s onboarding team walks you through each step—no guesswork.

Conclusion

With CMAT Advantage, non-invasive cardiovascular diagnostics no longer trade speed for depth. HealthWright Technologies medical devices deliver earlier disease detection, tighter workflows, and predictable expanded diagnostics—all in under ten minutes per patient.

Ready to get started? Learn how HealthWright Advantage bundles the device, training, and ongoing support your practice needs — backed by a 90-day buyback guarantee.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis, treatment, and clinical decision-making.

What Non-Invasive Cardiovascular Diagnostics Does HealthWright Offer?

HealthWright Technologies focuses on FDA-cleared, noninvasive diagnostics that fit into routine office visits. The flagship CMAT Advantage system combines vascular and autonomic assessment in a single workflow, measuring indices such as the ankle-brachial and toe-brachial index alongside heart rate variability and sudomotor function. For a closer look at the autonomic side of this testing, see our guide to cardiovascular autonomic neuropathy testing. These tools measure function and support the physician’s assessment; they do not, on their own, diagnose or treat disease.

How Do These Tools Fit Into a Practice Workflow?

Because the tests are noninvasive and take only a few minutes, they integrate into existing visit schedules with minimal disruption. Staff can be trained quickly, and results are available at the point of care to support timely clinical decisions. Practices typically adopt this capability through the CMAT Advantage program, which bundles the device with clinical training and billing guidance. Autonomic and vascular screening are often offered together; our overview of the PAD-to-ANS testing workflow explains how the services complement one another. To explore adding noninvasive cardiovascular diagnostics, visit our partnership page or contact HealthWright Technologies at contact@healthwrighttechnologies.com.

Frequently Asked Questions

What is the CMAT Advantage system?

CMAT Advantage is an FDA-cleared, noninvasive diagnostic program that assesses vascular and autonomic function — including ABI/TBI, heart rate variability, and sudomotor response — to support evaluation of peripheral arterial disease, diabetes complications, and cardiovascular risk. It supports the physician’s assessment and does not replace clinical judgment.

Are these cardiovascular diagnostics invasive?

No. The tests are noninvasive and typically completed in a few minutes in the office, improving patient comfort and compliance compared with invasive procedures.

Is the CMAT Advantage system FDA-approved?

The underlying device is FDA-cleared, not FDA-approved. FDA clearance (the 510(k) pathway) and FDA approval are different regulatory processes for medical devices.

What conditions can these tests help detect?

The assessments support evaluation of peripheral arterial disease, diabetes-related complications, and cardiovascular risk by measuring vascular and autonomic function. Diagnosis remains the responsibility of the treating physician.

How quickly can a practice adopt the technology?

The system is designed for fast adoption with a user-friendly workflow and staff training included through the CMAT Advantage program, minimizing disruption to daily operations.

This article is intended for healthcare professionals and is for general educational purposes only. It is not medical advice or a substitute for clinical judgment. Always verify coverage and coding with your payer.

CPT codes are provided for informational purposes only and do not guarantee reimbursement. Verify code applicability and coverage with the relevant payer and your billing department before submitting claims. CPT® is a registered trademark of the American Medical Association.